The groundbreaking approach of tirzepatide peptide represents a major advance in the care of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – GLP-1 and GIP – leading https://tirzepatidepeptide714630.webbuzzfeed.com/42366296/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment